Anti-emetic control with ondansetron in the chemotherapy of …
Emerging
7
Citations0
Refs1991
Year
Search Works
Work Details
- PMID https://pubmed.ncbi.nlm.nih.gov/1831629
- OpenAlex ID W2417483213
- Type Article
- Language EN
- Published 01 Jan 1991
- Volume 27 Suppl 1
- Pages S15–7; discussion S22
- Source PubMed
- Publisher National Institutes of Health
- FWCI 0.97
- Countries 1
- Institutions 1
- Added 24 Jun 2016
- Updated 27 Oct 2026
External Links
MENU
0
Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.
Article 1991 EN
Nausea and vomiting are significant problems in patients receiving outpatient chemotherapy for breast cancer. Three, randomised, double-blind studies comparing the efficacy and safety of ondansetron with placebo in patients receiving 14-day CMF (Study 1), and with metoclopramide in patients receiving FAC/FEC (Study 2) or EC (Study 3) are reviewed. Ondansetron was superior to placebo in Study 1; co…
7
Citations
0
References
1
Authors
0.97
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
1 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Norbert Walter Marschner Corresponding | Universitätsmedizin Göttingen (DE) |
Related Works
10Data: OpenAlex